Lumos Pharma, Inc. (LUMO) Tops Q2 EPS by 24c
Tweet
Share
E-mailGet Alerts LUMO Hot Sheet
Join SI Premium – FREE
Lumos Pharma, Inc. (NASDAQ: LUMO) reported Q2 EPS of ($0.93), $0.24 better than the analyst estimate of ($1.17). Revenue for the quarter came in at $490 thousand versus the consensus estimate of $265 thousand.
For earnings history and earnings-related data on Lumos Pharma, Inc. (LUMO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Movano (MOVE) Misses Q2 EPS by 195c
- AI/ML Innovations plans $2M private placement on the CSE
- Phillips 66, Marathon Merger Talks Collapsed - Semafor
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
